Page last updated: 2024-11-04

ponalrestat and ANS (Autonomic Nervous System) Diseases

ponalrestat has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faes, TJ1
Yff, GA1
DeWeerdt, O1
Lanting, P1
Heimans, JJ1
Bertelsmann, FW1
Sundkvist, G1
Lilja, B1
Rosén, I1
Agardh, CD1

Trials

2 trials available for ponalrestat and ANS (Autonomic Nervous System) Diseases

ArticleYear
Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor.
    Journal of neurology, 1993, Volume: 240, Issue:3

    Topics: Aldehyde Reductase; Autonomic Nervous System Diseases; Diabetic Neuropathies; Double-Blind Method; F

1993
Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function.
    Acta medica Scandinavica, 1987, Volume: 221, Issue:5

    Topics: Adult; Aldehyde Reductase; Autonomic Nervous System Diseases; Clinical Trials as Topic; Diabetic Neu

1987